Journal article
Immunity to HIV in early life
- Abstract:
- The developing immune system is adapted to the exposure to a plethora of pathogenic and non-pathogenic antigens encountered in utero and after birth, requiring a fine balance between protective immunity and immune tolerance. In early stages of life, this tolerogenic state of the innate and adaptive immune system and the lack of immunological memory render the host more susceptible to infectious pathogens like HIV. HIV pathogenesis is different in children, compared to adults, with more rapid disease progression and a substantial lack of control of viremia compared to adults. Plasma viral load remains high during infancy and only declines gradually over several years in line with immune maturation, even in rare cases where children maintain normal CD4 T-lymphocyte counts for several years without antiretroviral therapy (ART). These pediatric slow progressors also typically show low levels of immune activation despite persistently high viremia, resembling the phenotype of natural hosts of SIV infection. The lack of immunological memory places the fetus and the newborn at higher risk of infections; however, it may also provide an opportunity for unique interventions. Frequencies of central memory CD4+ T-lymphocytes, one of the main cellular reservoirs of HIV, are very low in the newborn child, so immediate ART could prevent the establishment of persistent viral reservoirs and result in “functional cure.” However, as recently demonstrated in the case report of the “Mississippi child” who experienced viral rebound after more than 2 years off ART, additional immunomodulatory strategies might be required for sustained viral suppression after ART cessation. In this review, we discuss the interactions between HIV and the developing immune system in children and the potential implications for therapeutic and prophylactic interventions.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, pdf, 837.5KB, Terms of use)
-
- Publisher copy:
- 10.3389/fimmu.2014.00391
Authors
- Publisher:
- Frontiers
- Journal:
- Frontiers in Immunology More from this journal
- Volume:
- 5
- Article number:
- 391
- Publication date:
- 2014-08-01
- DOI:
- EISSN:
-
1664-3224
- Keywords:
- Pubs id:
-
pubs:540171
- UUID:
-
uuid:3ab68189-6cb4-4bbf-9852-83579035f453
- Local pid:
-
pubs:540171
- Source identifiers:
-
540171
- Deposit date:
-
2015-08-21
- ARK identifier:
Terms of use
- Copyright holder:
- Muenchhoff et al
- Copyright date:
- 2014
- Notes:
- Copyright © 2014 Muenchhoff, Prendergast and Goulder. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record